Policies

Access to articles

Articles appearing in journals published by RHI are 'open access', and published under Creative Commons licenses. These provide an industry-standard framework to support easy re-use of open access (OA) material. Under Creative Commons licenses, authors retain copyright of their articles.

Advertising policy

1. All advertisements and commercially sponsored publications are independent from editorial decisions. RHI does not endorse any product or service marked as an advertisement or promoted by a sponsor in RHI publications. Editorial content is not compromised by commercial or financial interests, or by any specific arrangements with advertising clients or sponsors.
2. RHI reserves the right to decline any type of advertising that is damaging to the brand of RHI or is inappropriate to the content held on the RHI network.
3. RHI will not accept advertising for products or services known to be harmful to health (e.g. tobacco and alcohol products).
4. Advertisements may not be deceptive or misleading, and must be verifiable. Advertisements should clearly identify the advertiser and the product or service being offered. Exaggerated or extravagantly worded copy will not be allowed. Advertisements will not be accepted if they appear to be indecent or offensive in either text or artwork, or if they relate to content of a personal, racial, ethnic, sexual orientation, or religious nature.
5. Once an advertisement has been deployed online, it will be withdrawn from the journal site at any time if the Editor(s)-in-Chief or Publisher request its removal.
6. RHI will not allow any treatment-specific or drug-specific campaign to be targeted to a specific article(s) or on any page where content relates to the product(s) being advertised. (Advertisers may not link to articles using keywords; they may not target advertising for a specific product on the condition that it appear in the same location and at the same time as a specific article mentioning that product and they may not refer to an article published at the same time as the advertisement appears).
7. All advertisements for drug-specific campaigns must comply with the relevant European and UK legislation that regulates advertising. Information about the latest legislation, as well as good practice guidelines, can be found on the MHRA website. Advertisers should make available to RHI the marketing authorization and summary of product characteristics when submitting their advertisement. In the case of drug advertisements, the full generic name of each active ingredient should appear. Each page of an advertisement for a prescription-only medicine should be clearly labeled as intended for health professionals.
8. All advertisements for drug specific campaigns should encourage correct and rational use and must not be misleading.
9. Advertisements and editorial content must be clearly distinguishable. RHI will not publish “advertorial” content, and sponsored supplements must be clearly indicated as such. If a supplement did not undergo peer review or underwent a peer review-process different from the rest of the journal that should be explicitly stated.
10. Editorial decisions will not be influenced by current or potential sponsors and advertisers, and will not be influenced by marketing decisions. Advertisers and sponsors have no control or influence over the results of searches a user may conduct on the website by keyword or search topic.
11. If any advert is requested outside of RHI standard advertising positions, then a request should be made to editorial who will respond with a full and final decision within two business days.
12. Information about complaints concerning advertisements will be included in the Advertisements page.
13. We partner with third-party advertising companies to serve ads and/or collect certain information when you visit our website. These companies may use cookies or web beacons to collect non-personally identifiable information [not including your name, address, email address or telephone number] during your visit to this website to help show advertisements on other websites also likely to be of interest to you.

Permanency of articles

RHI has taken steps to ensure that all open access articles published by RHI are deposited in a number of safe open access archives. In addition, once an article has been published, we do not allow it to be changed, leading to the following policies.

Article corrections and retractions

Corrections to or retractions of published articles will be made by publishing a correction or retraction note and without altering the original article in any way other than to add a prominent link to the note. In this way, the original article remains in the public domain and the subsequent correction or retraction will be widely indexed.

Article removal

The preservation of scientific research is a cornerstone of science and as such we will use our best efforts to ensure that material published by RHI is preserved and remains available for access. However, in the exceptional event that material is considered to infringe certain rights or is defamatory we may have no option but to remove that material from our site and those sites on which we have deposited the material in question.

RHI therefore reserves the right to cease to make available articles, or relevant article content, that it has been advised are potentially defamatory or that infringe any intellectual property right, or are otherwise unlawful. Where this occurs the article will remain indexed. However, in place of the article or content an appropriate explanatory note will be attached. An example of such an explanatory note is as follows: "RHI regrets that this article is no longer available to avoid threatened legal claims".

"RHI regrets that this article is no longer available to avoid threatened legal claims"

Reprints and permissions

Reprint service

Reprint services are available for those requiring professional quality reproductions of articles. Reprints are produced from the final PDF of the article.

Prints can be ordered using the online ordering system provided by Sheridan Press. Please  click here  to access the simple ordering portal, and have reprints delivered to your door. For orders of 400+ copies, or for commercial reprints, please contact  Rajaie.journal@gmail.com . Open access articles

The open access articles published in RHI's journals are made available under a Creative Commons license, which means they are accessible online within the specific licence terms, and subject to proper attribution (which, in an academic context, usually means citation). To learn more about OA licences visit our  licensing and copyright guide For more information about reuse of Springer Nature content, please see the  Rights, Permissions & Third Party Distribution webpage . The re-use rights enshrined in our  license agreement  include the right for anyone to produce printed copies themselves, without formal permission or payment of permission fees. As a courtesy, however, anyone wishing to reproduce large quantities of an open access article (250+) should inform the copyright holder and we suggest a contribution in support of open access publication.

Figures and tables

Reproduction of figures or tables from any article is permitted free of charge and without formal written permission from the publisher or the copyright holder, provided that the figure/table is original, RHI is duly identified as the original publisher, and that proper attribution of authorship and the correct citation details are given as acknowledgment. If you have any questions about reproduction of figures or tables please  send email: Rajaie.journal@gmail.com

RHI Open access charter

Every peer-reviewed research article appearing in any journal published by RHI is 'open access', meaning that:

1. The article is universally and freely accessible via the Internet, in an easily readable format and deposited immediately upon publication, without embargo, in an agreed format - current preference is XML with a declared DTD - in at least one widely and internationally recognized open access repository (such as PubMed Central).

2. The author(s) or copyright owner(s) irrevocably grant(s) to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate the research article in its entirety or in part, in any format or medium, provided that no substantive errors are introduced in the process, proper attribution of authorship and correct citation details are given, and that the bibliographic details are not changed. If the article is reproduced or disseminated in part, this must be clearly and unequivocally indicated.RHI is committed permanently to maintaining this open access publishing policy, retrospectively and prospectively, in all eventualities, including any future changes in ownership.

RHI has established an independent Board of Trustees. If and when a change of ownership should be considered, the Board of Trustees will be asked to judge and advise whether sufficient guarantees to continue a policy of unconditional open access for research articles are being offered and agreed by any prospective new owner. RHI will not enter into a change of ownership agreement unless the Board of Trustees accepts these guarantees.

Any change in the composition of the Board of Trustees will be subject to approval by a majority of the existing members of the Board of Trustees.

Receiving email

How can I ensure that I receive RHI's emails? Occasionally, email sent by RHI may be caught by spam filters. Most modern email software includes a spam or junk folder, and it is worth checking this from time to time.

If you find emails from RHI in your spam or junk folder, you can tell your mail program that it is not spam by hitting the "Not spam" or "Not junk" button, and most mail programs will learn from this and will be less likely to misclassify subsequent emails. In order to guarantee that mail from RHI does not get caught by your spam filters, most systems also make it possible to create a list of “trusted senders”. Instructions are provided below for how to add RHI to your “trusted sender” list using Outlook , Apple Mail, Thunderbird, Gmail, Hotmail, Yahoo and Postini. Even if your ISP or email program is not listed, a similar approach will generally be possible.

Microsoft Outlook

1. On the Tools menu, click Options
2. On the Preferences tab, click Junk E-mail
3. On the Safe Senders tab, click Add
4. Where it says “Add address” enter rajaie.journal@gmail.com
5. Click OK

Apple Mail

1. Go to Mail > Preferences from your Mail menu
2. Go to the Rules tab
3. Select Add Rule
4. Give this rule a name such as "RHI"
5. Create a rule that says "If any of the following conditions are met: 'From' 'Contains'" and then enter rajair.journal@gmail.com
6. From the actions, select 'Move message' to mailbox 'Inbox'.
7. Click "OK"

Thunderbird

1. Click the Address Book button
2. Highlight the Personal Address Book
3. Click on "New Contact"
4. In the "Contact" tab of the new card, enter rajaie.journal@gmail.com to the email field
5. Click "Ok"
6. Select "Account settings > Junk Settings" from the side menu
7. Select "Enable adaptive junk mail controls for this account" and "Personal Address book"
8. Click "Ok"

Gmail

1. At the top right of the page, go to “Settings”, “Filters”, “Create a new filter”
2. Where it says “From”, enter rajaie.journal@gmail.com
3. Click "Next Step"
4. Click the box “Never send it to Spam”
5. Click “Create Filter”

Yahoo!

1. At the top left of the page click "Mail Options"
2. Select 'Filters' (in the bottom left corner)
3. On the Filters page, click "Add"
4. Add “Filter Name”
5. Select the “Sender”, and add "contains" then enter rajaie.journal@gmail.com
6. Click the ("Choose Folder") pull down menu and select 'Inbox'
7. Select “Save”

Postini

1. Log into your Postini account
2. Go to “My settings”, and then to “Approved senders”
3. In the “Approved domains” box, add rajaie.journal@gmail.com
4. Click “Update approved domains”